Tech Company Financing Transactions

Compass Therapeutics Funding Round

OrbiMed, Alexandria Venture Investments and Biomatics Capital Partners participated in a $49 million Series A venture round for Compass Therapeutics. The round was announced on 7/13/2018.

Transaction Overview

Announced On
7/13/2018
Transaction Type
Venture Equity
Amount
$49,000,000
Round
Series A
Proceeds Purpose
This financing will enable the company to advance its next-generation antibody-based therapeutics into the clinic.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
245 1st St. 3rd Floor
Cambridge, MA 02142
USA
Email Address
Overview
Comprehensively drugging the tumor-immune synapse with human antibodies against over 50 cell surface and soluble targets. Combining and engineering the best antibody leads in our proprietary Targeted Immunomodulation platform approach.
Profile
Compass Therapeutics LinkedIn Company Profile
Social Media
Compass Therapeutics Company Twitter Account
Company News
Compass Therapeutics News
Facebook
Compass Therapeutics on Facebook
YouTube
Compass Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Schuetz Thomas
  Schuetz Thomas LinkedIn Profile  Schuetz Thomas Twitter Account  Schuetz Thomas News  Schuetz Thomas on Facebook
Chief Operating Officer
Jeb Ledell
  Jeb Ledell LinkedIn Profile  Jeb Ledell Twitter Account  Jeb Ledell News  Jeb Ledell on Facebook
Chief Scientific Officer
Piotr Bobrowicz
  Piotr Bobrowicz LinkedIn Profile  Piotr Bobrowicz Twitter Account  Piotr Bobrowicz News  Piotr Bobrowicz on Facebook
VP - Engineering
Michael Schmidt
  Michael Schmidt LinkedIn Profile  Michael Schmidt Twitter Account  Michael Schmidt News  Michael Schmidt on Facebook
VP - Human Resources
Sara Mannle
  Sara Mannle LinkedIn Profile  Sara Mannle Twitter Account  Sara Mannle News  Sara Mannle on Facebook
VP - Manufacturing
Greg Zarbis-Papastoitsis
  Greg Zarbis-Papastoitsis LinkedIn Profile  Greg Zarbis-Papastoitsis Twitter Account  Greg Zarbis-Papastoitsis News  Greg Zarbis-Papastoitsis on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/12/2018: Tamr venture capital transaction
Next: 7/13/2018: ORIG3N venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary